EDGAR Filing Documents for 0001193125-24-236039

Form 8-K - Current report:

SEC Accession No. 0001193125-24-236039

Filing Date

2024-10-10

Accepted

2024-10-10 17:31:01

Documents

Period of Report

2024-10-09

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d882121d8k.htm iXBRL	8-K	78739
2	EX-4.1	d882121dex41.htm	EX-4.1	87435
3	EX-4.2	d882121dex42.htm	EX-4.2	107820
4	EX-4.3	d882121dex43.htm	EX-4.3	107800
5	EX-10.1	d882121dex101.htm	EX-10.1	224588
6	EX-10.2	d882121dex102.htm	EX-10.2	133173
7	EX-10.3	d882121dex103.htm	EX-10.3	49373
8	EX-10.4	d882121dex104.htm	EX-10.4	24005
9	EX-10.5	d882121dex105.htm	EX-10.5	31595
10	EX-99.1	d882121dex991.htm	EX-99.1	13893
14	GRAPHIC	g882121g1009165635519.jpg	GRAPHIC	3147
15	GRAPHIC	g882121g1009205115412.jpg	GRAPHIC	13724
	Complete submission text file	0001193125-24-236039.txt		1243412

Data Files

Seq	Description	Document	Type	Size
11	XBRL TAXONOMY EXTENSION SCHEMA	ikt-20241009.xsd	EX-101.SCH	2857
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ikt-20241009_lab.xml	EX-101.LAB	18738
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ikt-20241009_pre.xml	EX-101.PRE	11713
26	EXTRACTED XBRL INSTANCE DOCUMENT	d882121d8k_htm.xml	XML	3768

Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339

Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419

Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)